Event
1 April, 2025
11:00 am - 12:00 pm

Breaking boundaries: innovation at the frontier of cancer research

Cancer is an illness that has affected most people, either personally, or through a family member or friend. Yet the UK has some of the poorest cancer survival rates in the developed world, with the potential for thousands more lives to be saved through earlier detection, improved access to treatment and innovative medicines.

Exciting developments are happening across the cancer pathway. In the face of huge backlogs, staff are constantly innovating on the ground to ensure that referral to treatment is as quick as possible. All the while, cancer drugs are redefining what is possible in treating the disease. Anti-body drug conjugates (ADCs) for example, have a highly specific targeting ability, achieving an efficient and accurate elimination of cancer cells without damaging the surrounding cells.

The potential for new practices and innovative medicines to improve care and save lives is enormous, but developing and adopting these treatments is contingent on removing the barriers to innovation and implementation.

Re:State is delighted to welcome Professor Peter Johnson, National Clinical Director for Cancer, NHS England, to discuss the potential of these exciting developments in cancer treatments to transform care, so that patients can reap the benefits.

This private roundtable will be held in-person and will take place under the Chatham House rule and is kindly supported by Pfizer.